Market Leader Ingenious Med is the largest and most trusted electronic charge capture provider in healthcare, with more than twenty-five years of experience and a physician-designed platform. This credible track record makes them a compelling partner for hospital systems pursuing revenue cycle optimization and improved operational efficiency. Target decision makers such as CFOs and Revenue Cycle leaders at mid-to-large health systems and integrated delivery networks to consolidate charge capture across departments and improve cash flow.

Automation Edge Recent product innovations demonstrate a strong focus on automation and resilience. The company launched the Charge Note Reconciliation tool to reduce resource spend, and added COVID-19 response features across its platform at no extra cost. These capabilities position Ingenious Med to modernize aging RCM stacks, adapt to evolving payer rules, and reduce denials for health networks seeking cost efficiencies.

Leadership Momentum Strategic leadership moves signal growth readiness. Harris Novum acquired Ingenious Med in 2021, Scott Thomas was named CEO in 2023, and the company publicly engaged at industry events such as MGMA Focus | Financial Conference in 2025. This backing and momentum can be appealing to large hospital systems seeking stable, growth-focused technology partners and potential cross-portfolio collaborations.

Market Validation Market validation is evident through independent research and active industry engagement. Sage Growth Partners conducted a 101-industry-leader survey for Ingenious Med in 2024, and the firm’s MGMA appearance underscores CFO-level interest. With revenue in the 100–250 million range and a mid-sized employee base, the company is positioned to appeal to mid-to-large health systems and regional networks evaluating RCM modernization.

Growth Readiness Regional strength and growth scalability. Based in Atlanta with a mid-size team, Ingenious Med has a defensible footprint in the U.S. hospital market. The physician-led, high-performance platform can be leveraged to win mid-market accounts and scale toward national health networks, especially where clinical alignment and user adoption are critical to RCM success. Opportunities exist to expand through partner ecosystems and cross-sell within related health IT services.